Skip to content

Bilateral erector spinal block on opioid spare effect in upper abdominal surgery: a bicenter prospective controlled study

Bilateral erector spinal block versus paravertebral block for analgesia in upper abdominal surgery: a bicenter randomised controlled non-inferiority study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073030
Enrollment
Unknown
Registered
2023-06-30
Start date
2023-06-30
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper abdominal disease

Interventions

Erector spinae plane block group:Bilateral erector spinae plane block
Paravertebral block group:Bilateral paravertebral block

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) American Society of Anesthesiologists (ASA) Physical Status classification: I-III 2) Patients aged 18-75 years 3) Median upper abdominal incision with an estimated operation time of 3h±0.5h 4) Participants provided written informed consent 5) Scheduled for upper abdominal surgery

Exclusion criteria

Exclusion criteria: 1) Opioid abuse 2) Chronic pain and using analgesics before surgery 3) The therapy of corticosteroids before surgery 4) Motion sickness 5) Cognitive disorder 6) Contraindications for erector spinal block, paravertebral block (history of severe coagulopathy, infection, or allergy to local anesthetic) 7) 18.5=BMI=30kg/m2 8) Organic heart disease and severe arrhythmia 9) Hepatic, renal disorders 10) Palliative surgery, emergent surgery or reoperation

Design outcomes

Primary

MeasureTime frame
cumulative sufentanil equivalents during the surgery;

Secondary

MeasureTime frame
perioperative consumption of sufentanil ;NRS scores at 3, 6 12 and 24 h after surgery;the quality of recovery-15 score at 24 and 48h;relevant complications of nerve block such as infection, local hematoma, and pneumothorax; ;

Countries

China

Contacts

Public ContactTao Xu

Shanghai Changhai Hospital

xutaosci@163.com+86 135 0197 6460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026